An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy.
2016
An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
38
References
26
Citations
NaN
KQI